---
title: "Vor Bio appoints former Verona Pharma CEO David Zaccardelli to board"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291971310.md"
description: "Vor Biopharma Inc. has appointed David Zaccardelli to its board of directors. Zaccardelli brings over 20 years of biotech leadership experience, having previously served as CEO of Verona Pharma until its acquisition by Merck and led Dova Pharmaceuticals through its sale. Concurrently, RA Capital Management advisor Andrew Levin stepped down from the board to facilitate this appointment."
datetime: "2026-07-07T20:01:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291971310.md)
  - [en](https://longbridge.com/en/news/291971310.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291971310.md)
---

# Vor Bio appoints former Verona Pharma CEO David Zaccardelli to board

-   Vor Bio appointed David Zaccardelli to its board, adding a biotech executive with more than 20 years of industry leadership experience. \* Zaccardelli was CEO of Verona Pharma from 2020 until its USD 10 billion acquisition by Merck in October 2025. \* He previously led Dova Pharmaceuticals through its sale to Swedish Orphan Biovitrum in 2019 for up to USD 915 million. \* RA Capital Management advisor Andrew Levin stepped down from the board in connection with the appointment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607071601PRIMZONEFULLFEED9758409) on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [VOR.US](https://longbridge.com/en/quote/VOR.US.md)
- [VRNA.US](https://longbridge.com/en/quote/VRNA.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [RA Capital Healthcare Fund disposes of 213 Vor Biopharma shares worth $4,206.75](https://longbridge.com/en/news/293385729.md)
- [Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | VOR Stock News](https://longbridge.com/en/news/291592393.md)
- [Relmada Therapeutics names Bipin Dalmia chief business officer](https://longbridge.com/en/news/294066297.md)
- [Nektar Therapeutics $NKTR Shares Acquired by Swiss National Bank](https://longbridge.com/en/news/294328549.md)
- [First Trust Advisors LP Sells 2,586 Shares of Madrigal Pharmaceuticals, Inc. $MDGL](https://longbridge.com/en/news/294471972.md)